World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
62
Citations
15391
World Ranking
2851
National Ranking
78

Benita Yip publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Benita Yip sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 150 publications — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Benita Yip D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Benita Yip sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 62 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Benita Yip is affiliated with the University of British Columbia in Canada, focusing on research primarily in the fields of medicine and immunology and microbiology. Their work predominantly addresses infectious diseases, with significant contributions in emergency medicine, virology, and epidemiology. The main topics covered in their research include HIV/AIDS research and interventions, HIV-related health complications and treatments, HIV research and treatment, HIV/AIDS drug development and treatment, and aspects relating to HIV, drug use, and sexual risk.

Their recent publications demonstrate engagement with current issues in HIV/AIDS care and treatment. Selected papers include:

  • "Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005-2015" (2020) published in The Journal of Infectious Diseases
  • "Increased CD4: CD8 Ratio Normalization with Implementation of Current ART Management Guidelines" (2020) published in Journal of Antimicrobial Chemotherapy
  • "CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018" (2020) published in Clinical Infectious Diseases

The venues where Benita Yip has been published include:

  • The Journal of Infectious Diseases
  • Journal of Antimicrobial Chemotherapy
  • Clinical Infectious Diseases

Frequent coauthors who have collaborated with them include:

  • Richard D. Moore
  • Keri N. Althoff
  • Michael A. Horberg
  • Mari M. Kitahata
  • Heidi M. Crane

Benita Yip's research contributions emphasize topics central to HIV/AIDS public health challenges. This includes studies of hospitalization rates among persons living with HIV, immunological response markers such as the CD4 to CD8 ratio in the context of antiretroviral therapy, and comprehensive assessment of clinical care entry points and therapy prescription trends across a large population-base in North America.

Best Publications

  • Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy

    Robert S. Hogg;Katherine V. Heath;Benita Yip;Kevin J. P. Craib

  • Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy

    Robert S. Hogg;Benita Yip;Keith J. Chan;Evan Wood

  • Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study

    Julio S.G. Montaner;Julio S.G. Montaner;Julio S.G. Montaner;Viviane D. Lima;Viviane D. Lima;Rolando Barrios;Benita Yip

  • Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users

    Steffanie A. Strathdee;Anita Palepu;Peter G. A. Cornelisse;Benita Yip

  • Predictors of HIV Drug-Resistance Mutations in a Large Antiretroviral-Naive Cohort Initiating Triple Antiretroviral Therapy

    P. Richard Harrigan;Robert S. Hogg;Winnie W. Y. Dong;Benita Yip

  • Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up.

    Robert S Hogg;Katherine Heath;David Bangsberg;Benita Yip

  • Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L.

    Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan

  • Decline in deaths from AIDS due to new antiretrovirals.

    Robert S Hogg;Michael V O'Shaughnessy;Nada Gataric;Benita Yip

  • Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.

    R. S. Hogg;B. Yip;C. Kully;K. J. P. Craib

  • Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting

    Julio S.G. Montaner;Viviane D. Lima;P. Richard Harrigan;Lillian Lourenço

  • The combined effect of modern highly active antiretroviral therapy regimens and adherence on mortality over time.

    Viviane D Lima;Richard Harrigan;David R Bangsberg;Robert S Hogg;Robert S Hogg

  • Adherence to triple therapy and viral load response.

    Sophie Low-Beer;Benita Yip;Michael V. O'Shaughnessy;Robert S. Hogg

  • Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.

    Viviane D. Lima;Robert S. Hogg;P. Richard Harrigan;David Moore

  • Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users

    Evan Wood;Julio S.G. Montaner;Benita Yip;Mark W. Tyndall

  • The cascade of HIV care in British Columbia, Canada, 1996-2011: a population-based retrospective cohort study.

    Bohdan Nosyk;Bohdan Nosyk;Julio S G Montaner;Guillaume Colley;Viviane D Lima

  • Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort

    Zachary Tanner;Nathan Lachowsky;Nathan Lachowsky;Erin Ding;Hasina Samji

  • Highly active antiretroviral therapy and survival in HIV-infected injection drug users.

    Evan Wood;Robert S. Hogg;Viviane Dias Lima;Thomas Kerr

  • Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.

    Robert S Hogg;Robert S Hogg;David R Bangsberg;Viviane D Lima;Chris Alexander

  • A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.

    Robert Gross;Benita Yip;Vincent Lo Re;Evan Wood

  • Discordant immunologic and virologic responses to highly active antiretroviral therapy are associated with increased mortality and poor adherence to therapy.

    David M Moore;Robert S Hogg;Benita Yip;Evan Wood

  • The impact of adherence on CD4 cell count responses among HIV-infected patients.

    Evan Wood;Robert S. Hogg;Benita Yip;P. Richard Harrigan

Frequent Co-Authors

Robert S. Hogg
Robert S. Hogg Simon Fraser University
Julio S. G. Montaner
Julio S. G. Montaner University of British Columbia
Viviane D. Lima
Viviane D. Lima University of British Columbia
P. Richard Harrigan
P. Richard Harrigan University of British Columbia
Michael V. O'Shaughnessy
Michael V. O'Shaughnessy University of California, San Francisco
Evan Wood
Evan Wood University of British Columbia
Martin T. Schechter
Martin T. Schechter University of British Columbia
Mark W. Tyndall
Mark W. Tyndall University of British Columbia
Amy C. Justice
Amy C. Justice Yale University
Zabrina L. Brumme
Zabrina L. Brumme Simon Fraser University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternatives to traditional microbiology degrees can open doors to diverse and rewarding careers. For those interested in healthcare but seeking different roles, becoming a child life specialist offers a unique opportunity to support children and families in medical settings. Understanding how much do child life specialists make can help guide decisions about this career path.

Individuals with criminal records might worry about their educational prospects. Fortunately, some of the best degree for felons programs provide accessible, online options that help overcome barriers to higher education and employment in fields related to health sciences.

For healthcare professionals seeking advanced clinical roles, pursuing qualifications as a functional nurse practitioner combines holistic health approaches with traditional nursing, expanding career opportunities and patient impact.

On the administrative side of healthcare, medical coding offers stable, in-demand roles. Learning more about cpc medical coding salary and career paths can provide insight into viable options beyond laboratory work. Each of these pathways complements a strong foundation in science, offering multiple routes to success.

Best Scientists Citing Benita Yip

Trending Scientists

Recently Published Articles